Cell Impact AB (SE:CI)

:CI

Cell Impact AB

RESEARCH TOOLSreports

Want to see SE:CI full AI Analyst Report?

Cell Impact AB (CI) Price & Analysis

2 Followers

CI Stock Chart & Stats

kr0.26

>-kr0.01(-4.05%)

At close: Mar 06 4:00 PM EST

kr0.26

>-kr0.01(-4.05%)

Day’s Range― - ―

52-Week Rangekr0.09 - kr0.74

Previous CloseN/A

Volume1.37M

Average Volume (3M)4.50M

Market Cap

kr124.90M

Enterprise Valuekr85.95M

Total Cash (Recent Filing)kr10.86M

Total Debt (Recent Filing)kr32.54M

Price to Earnings (P/E)―

Beta1.04

Next Earnings

May 20, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.19

Shares Outstanding589,169,500

10 Day Avg. Volume6,494,872

30 Day Avg. Volume4,501,845

Financial Highlights & Ratios

PEG Ratio>-0.01

Price to Book (P/B)0.27

Price to Sales (P/S)5.83

P/FCF Ratio-0.69

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)-0.48

Revenue Forecast (FY)kr40.00M

Bulls Say, Bears Say

Bulls Say

Proprietary Forming TechnologyCell Impact's proprietary high‑velocity forming technology is a durable competitive asset in the hydrogen value chain. It creates technical barriers, supports differentiation on tooling and volume production, and underpins long-term supplier value to fuel cell and electrolyzer OEMs during industrialization and scale-up.

Revenue Tied To Industrialization And Serial ProductionThe business model combines serial volume supply with development and tooling services, giving recurring revenue potential as customers scale. Service revenues tied to industrialization increase customer stickiness and create multi-stage engagement that can sustain revenue as clients move from prototyping to mass production.

Low Reported LeverageReported low debt relative to equity provides financial flexibility despite losses. Moderately low leverage reduces near-term refinancing pressure and preserves optionality to raise capital or invest in production tooling, which supports operational recovery over the coming months if execution stabilizes.

Bears Say

Sharp Revenue CollapseA steep drop in revenue dramatically reduces scale benefits and weakens customer diversification. The collapse undermines supply‑chain leverage and cost absorption, making profitable serial production harder to achieve and increasing the difficulty of recovering margins within a 2–6 month horizon.

Sustained Negative Cash FlowPersistent operating and free cash flow deficits indicate the core business is not self-funding. Continued cash burn forces reliance on external financing, which can dilute shareholders or constrain investment in production capacity and customer projects, limiting the firm's ability to execute industrialization plans.

Persistent Negative Margins And ReturnsDeeply negative margins and multi-year losses signal structural cost or pricing issues. Negative ROE and recurring net losses erode equity and reduce strategic flexibility, making it harder to scale profitably even if demand recovers, and increasing the risk that business fixes are required before sustainable profitability.

CI FAQ

What was Cell Impact AB’s price range in the past 12 months?

Cell Impact AB lowest stock price was kr0.09 and its highest was kr0.74 in the past 12 months.

What is Cell Impact AB’s market cap?

Cell Impact AB’s market cap is kr124.90M.

When is Cell Impact AB’s upcoming earnings report date?

Cell Impact AB’s upcoming earnings report date is May 20, 2026 which is in 21 days.

How were Cell Impact AB’s earnings last quarter?

Cell Impact AB released its earnings results on Feb 13, 2026. The company reported -kr0.189 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.189.

Is Cell Impact AB overvalued?

According to Wall Street analysts Cell Impact AB’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Cell Impact AB pay dividends?

Cell Impact AB does not currently pay dividends.

What is Cell Impact AB’s EPS estimate?

Cell Impact AB’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Cell Impact AB have?

Cell Impact AB has 589,169,500 shares outstanding.

What happened to Cell Impact AB’s price movement after its last earnings report?

Cell Impact AB reported an EPS of -kr0.189 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Cell Impact AB?

Currently, no hedge funds are holding shares in SE:CI

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Cell Impact AB

Cell Impact AB (CI) is a Swedish company specializing in the development and production of advanced fuel cell components, primarily focusing on bipolar plates for hydrogen fuel cells. The company operates within the renewable energy sector, aiming to contribute to the transition towards sustainable energy solutions. CI's core products include innovative flow plates that enhance the efficiency and performance of fuel cells, catering to various applications such as transportation, stationary power generation, and backup power systems.